awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33427979-C874FAC8-FFBA-4E94-A536-57E04EC04DC3
Q33427979-C874FAC8-FFBA-4E94-A536-57E04EC04DC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33427979-C874FAC8-FFBA-4E94-A536-57E04EC04DC3
A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma.
P2860
Q33427979-C874FAC8-FFBA-4E94-A536-57E04EC04DC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33427979-C874FAC8-FFBA-4E94-A536-57E04EC04DC3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e607d642e83cb1ff02ce9388c37585e738f2c72b
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.